These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10903645)

  • 41. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
    Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
    Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional heartburn: what it is and how to treat it.
    Fass R
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):23-33, v. PubMed ID: 19232278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
    de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescribing costs. Braking point.
    Reid E; Cooke J; Johnson R; McKnight H
    Health Serv J; 2000 May; 110(5705):28-30. PubMed ID: 11183327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial.
    Krol N; Wensing M; Haaijer-Ruskamp F; Muris JW; Numans ME; Schattenberg G; Balen J; Grol R
    Aliment Pharmacol Ther; 2004 Apr; 19(8):917-22. PubMed ID: 15080853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blinded randomised controlled study of the effect of a discharge communication template on proton pump inhibitor prescribing.
    Lampen-Smith A; Young J; O'Rourke MA; Balram A; Inns S
    N Z Med J; 2012 Feb; 125(1350):30-6. PubMed ID: 22382254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
    Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
    Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
    Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Heartburn: in short-term treatment you have the choice!].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
    [No Abstract]   [Full Text] [Related]  

  • 53. Proton pump inhibitors for dyspepsia.
    Vakil N
    Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescription-equivalent over-the-counter drugs for allergy, heartburn, and cholesterol reduction.
    Curtiss FR
    J Manag Care Pharm; 2005; 11(1):94-6. PubMed ID: 15667239
    [No Abstract]   [Full Text] [Related]  

  • 55. Employers need to have a wider horizon than drug costs alone when considering the implementation of health care intervention programs.
    Wahlqvist P
    J Manag Care Pharm; 2006 Sep; 12(7):581-2; author reply 582-3. PubMed ID: 16981804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension].
    Uzan M; Uzan S; Sureau C; Richard-Berthe C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):569-72. PubMed ID: 2848305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness and cost-utility of long-term management strategies for heartburn.
    Goeree R; O'Brien BJ; Blackhouse G; Marshall J; Briggs A; Lad R
    Value Health; 2002; 5(4):312-28. PubMed ID: 12102694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hold it! Are you taking your reflux meds correctly? PPIs for heartburn and GERD are effective--but only when used according to directions.
    Johns Hopkins Med Lett Health After 50; 2014 Oct; 26(10):3. PubMed ID: 25306565
    [No Abstract]   [Full Text] [Related]  

  • 59. CUSUM charts for monitoring clinical practice quality using primary care prescribing data: a case study of an initiative to encourage generic prescribing of proton pump inhibitors.
    Wood J; Lambert MF
    J Clin Pharm Ther; 2011 Dec; 36(6):680-6. PubMed ID: 21143614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR; Marzella N
    Clin Ther; 2010 Aug; 32(9):1578-96. PubMed ID: 20974316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.